Expanding Subcutaneous Design Brick By Brick: The BD Neopak™ Glass Prefillable Syringe Platform

As subcutaneous biologics continue to evolve toward higher concentrations, larger volumes and greater formulation complexity, traditional delivery systems are being pushed beyond their intended limits. Explore how the BD Neopak™ Glass Prefillable Syringe platform was designed as a modular, future-ready system that expands the subcutaneous drug delivery design space through a series of complementary technology “bricks.” The authors examine how innovations such as BD Neopak™ XSi™ and BD Neopak™ XtraFlow™ address critical challenges including drug-container compatibility, high-viscosity delivery, injection force and patient experience.

Beyond hardware innovation, view highlights emerging digital technologies that connect manufacturing and delivery data to support traceability, operational excellence and future AI-enabled insights. By combining materials science, engineering and data-driven approaches, the platform demonstrates how primary containers can evolve from passive packaging components into active enablers of biologic combination product success, helping developers navigate increasingly demanding therapeutic and regulatory landscapes.